Safety and Efficacy Study of Cells Sheet-Autologous Chondrocyte Implantation to Treat Articular Cartilage Defects
CS-ACI
A Prospective Open-label Multi-center Study to Demonstrate the Safety and Efficacy of Cells Sheet-Autologous Chondrocyte Implantation(CS-ACI)for the Treatment of Articular Cartilage Defects
1 other identifier
interventional
10
1 country
3
Brief Summary
In this study,the Autologous chondrocyte implantation (ACI)technology and cell sheet technology are used to Cells Sheet-Autologous Chondrocyte Implantation(CS-ACI) for treating Cartilage Defects.The Safety and Efficacy Study of CS-ACI are evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Apr 2012
Typical duration for phase_1
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 24, 2012
CompletedFirst Posted
Study publicly available on registry
September 27, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedOctober 1, 2012
September 1, 2012
1.2 years
September 24, 2012
September 28, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean change from baseline in the MRI
3month,6 month, 12 months, 24 months
Secondary Outcomes (2)
Change from Baseline in the Lysholm
3month,6 month, 12 months, 24 months
Change from Baseline in the Knee injury and Osteoarthritis Outcome Score (KOOS)Which consists of five sub- categories = Pain, ADL, QOL, Symptoms, Sport
3month,6 month, 12 months, 24 months
Study Arms (1)
CS-ACI
EXPERIMENTALGroup/Cohort Label: pretherapy post-treatment Group/Cohort Description :The CS-ACI is used to prepare cell sheet and implant to the Cartilage defects.The arm of safety and efficacy are compared preoperative observation with postoperative observation.
Interventions
Procedure: Self-control. Cells Sheet-Autologous Chondrocyte Implantation(CS-ACI) includes an arthroscopy for harvesting of cartilage 6-8 weeks prior to the open cartilage surgery. Other Names: Cells Sheet-Autologous Chondrocyte Implantation (CS-ACI)
Eligibility Criteria
You may qualify if:
- Male or female patients, age: between 18 and 50 years
- Defect: isolated ICRS grade III or IV single defect chondral lesions on Articular Cartilage
- Defect size: 2.5 to \< 5 cm2 after debridement to healthy cartilage up to 6 mm in depth.
- Nearly intact chondral structure surrounding the defect as well as an intact corresponding joint area
- Informed consent signed and dated by patient and Patient understands the strict rehabilitation protocol and follow-up programme and is willing to follow it
- No ligament damage or ligament damage after reconstruction
You may not qualify if:
- Patients younger than 18 years and older than 50 years.
- Arthrofibrosis or Ankylosis
- Arthritis
- Obesity
- Infectious diseases
- the other cases of patients which Doctors determine not participate in the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yan Jinlead
- Xijing Hospitalcollaborator
- Tang-Du Hospitalcollaborator
Study Sites (3)
Xijing Hospital
Xi'an, 710032, China
Tangdu Hospital
Xi'an, 710038, China
Xi'An Honghui Hospital
Xi'an, 710054, China
Related Publications (1)
Ebihara G, Sato M, Yamato M, Mitani G, Kutsuna T, Nagai T, Ito S, Ukai T, Kobayashi M, Kokubo M, Okano T, Mochida J. Cartilage repair in transplanted scaffold-free chondrocyte sheets using a minipig model. Biomaterials. 2012 May;33(15):3846-51. doi: 10.1016/j.biomaterials.2012.01.056. Epub 2012 Feb 25.
PMID: 22369960BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jin Yan, Ph.D
Research and Development Center for Tissue Engineering,Fourth Military Medical University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of Research and Development Center for Tissue Engineering
Study Record Dates
First Submitted
September 24, 2012
First Posted
September 27, 2012
Study Start
April 1, 2012
Primary Completion
July 1, 2013
Study Completion
June 1, 2015
Last Updated
October 1, 2012
Record last verified: 2012-09